Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia  Takahiro Omori, MD, Michihiko Tajiri, MD, PhD, Tomohisa Baba, MD,
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Collision Tumor of Esophagus: Report of Three Cases
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis  Takekazu Iwata, MD, PhD, Shigetoshi Yoshida,
Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy  San-Gang Wu, MD, Feng-Yan Li, MD,
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
High Expression of Zinc-Binding Protein-89 Predicts Decreased Survival in Esophageal Squamous Cell Cancer  Shu-Mei Yan, MD, Hui-Ni Wu, MB, Fan He, MD,
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis  Naoto Morimoto,
David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L
Operative Results and Outcomes in Children With Shone's Anomaly
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Demographic, Psychosocial, and Behavioral Factors Associated With Survival After Heart Transplantation  Steven A. Farmer, MD, PhD, Kathleen L. Grady,
Coexistent Pulmonary Inflammatory Pseudotumor and Carcinoma in One Patient: Does Positron Emission Tomography/Computed Tomography Help  Zhi Zheng, MD,
Lung Cancer Surgery in Patients With Liver Cirrhosis
Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer  Shawn S. Groth, MD, MS, Natasha.
Who Do You Say You Are? The Annals of Thoracic Surgery
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Use of Amiodarone After Major Lung Resection
Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer  Takayuki Fukui, MD, Toshiki Okasaka, MD, Koji Kawaguchi,
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms  Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,
Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.
Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer  Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,
Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer  Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.
Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W
Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases  Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.
Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy  Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,
Surgical Therapy for Bilateral Multiple Primary Lung Cancer
Gerald G.R. Sng, Cameron D. Wright, MD  The Annals of Thoracic Surgery 
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma  Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.
Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer  Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.
Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma  Manabu Emi, MD, PhD, Jun Hihara, MD, PhD, Yoichi Hamai, MD, PhD, Takaoki Furukawa,
Clinicopathologic Features and Computed Tomographic Findings of 52 Surgically Resected Adenosquamous Carcinomas of the Lung  Yukio Watanabe, MD, Koji.
Editorial Board, January 2010
Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit  George M. Alfieris, MD, Michael F. Swartz, PhD,
Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus  Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
The Annals of Thoracic Surgery
Carcinoma of the esophagus: Prognostic significance of histologic type
Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma  Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,
Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung  Florian Eichhorn, MD, Hendrik Dienemann, MD,
Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer  Pamela Samson, MD, MPHS, Varun.
Prognosis of Patients With Pathologic T0 N+ Esophageal Squamous Cell Carcinoma After Chemoradiotherapy and Surgical Resection: Results From a Nationwide.
Lymph Node Staging by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients With Small Cell Lung Cancer  Hironobu Wada, MD, Takahiro.
Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience  Hua Li, MD, PhD, Deming Xu,
The Additional Prognostic Value of Left Atrial Volume on the Outcome of Patients After Surgical Ventricular Reconstruction  Serenella Castelvecchio, MD,
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
Pulmonary Embolectomy for Acute Massive Pulmonary Embolism
Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer  Masafumi Yamaguchi, MD, PhD, Gouji Toyokawa, MD,
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer  Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Mark I. Block, MD  The Annals of Thoracic Surgery 
Completely Resected Non-Small Cell Lung Cancer: Reconsidering Prognostic Value and Significance of N2 Metastases  Marc Riquet, MD, PhD, Patrick Bagan,
Late Consequences of a Much Earlier Decision
The Impact of New Technology on Cardiothoracic Surgical Practice
Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support  Peter B. Manning, MD, Michael J. Rutter, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms  Robert E. Merritt, MD, Douglas J. Mathisen,
Surgical Resection of Pulmonary Malignant Tumors After Living Donor Liver Transplantation  Fumihiro Shoji, MD, Daigo Kawano, MD, Toru Ikegami, MD, Yuji.
Presentation transcript:

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji Yamazaki, MD, PhD, Takuro Kometani, MD, Yoshihiko Maehara, MD, PhD  The Annals of Thoracic Surgery  Volume 81, Issue 4, Pages 1189-1193 (April 2006) DOI: 10.1016/j.athoracsur.2005.09.028 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 The relationship between the pack-year index (PYI) and the prognosis-proportion of pathologic stage in squamous cell carcinoma. (A) Survival curves of subgroups classified by smoking status. Patients with squamous cell carcinoma were classified to four subgroups according to their PYI, and the respective survival curves were statistically analyzed. (B) The proportion and number of patients with squamous cell carcinoma in the subgroups according to PYI were shown. The Annals of Thoracic Surgery 2006 81, 1189-1193DOI: (10.1016/j.athoracsur.2005.09.028) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 The relationship between the pack-year index (PYI) and the prognosis-proportion of pathologic stage in adenocarcinoma. (A) Survival curves of subgroups classified by smoking status. Patients with adenocarcinoma were classified to four subgroups according to their PYI, and the respective survival curves were statistically analyzed. (B) The proportion and number of patients with adenocarcinoma in the subgroups according to PYI score were shown. The Annals of Thoracic Surgery 2006 81, 1189-1193DOI: (10.1016/j.athoracsur.2005.09.028) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions